AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 290 filers reported holding AVANOS MED INC in Q3 2019. The put-call ratio across all filers is 0.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $534,962 | +102.1% | 26,869 | +127.7% | 0.00% | 0.0% |
| Q4 2023 | $264,674 | -42.0% | 11,800 | -10.3% | 0.00% | 0.0% |
| Q4 2021 | $456,000 | +29.2% | 13,148 | +35.5% | 0.00% | 0.0% |
| Q2 2021 | $353,000 | -16.7% | 9,700 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $424,000 | -42.6% | 9,700 | -39.8% | 0.00% | -50.0% |
| Q4 2020 | $739,000 | -35.5% | 16,100 | -53.3% | 0.00% | 0.0% |
| Q3 2020 | $1,146,000 | +19.6% | 34,500 | +5.8% | 0.00% | -33.3% |
| Q2 2020 | $958,000 | -29.0% | 32,600 | -34.9% | 0.00% | -66.7% |
| Q1 2020 | $1,349,000 | -5.7% | 50,101 | +31.2% | 0.01% | 0.0% |
| Q3 2019 | $1,431,000 | +144.6% | 38,200 | +178.8% | 0.01% | +200.0% |
| Q1 2019 | $585,000 | -60.7% | 13,700 | -58.8% | 0.00% | -66.7% |
| Q4 2018 | $1,489,000 | -27.0% | 33,247 | +11.6% | 0.01% | 0.0% |
| Q3 2018 | $2,041,000 | – | 29,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 2,441,913 | $88,812,000 | 4.12% |
| RGM Capital, LLC | 2,157,612 | $78,472,000 | 3.63% |
| Millrace Asset Group, Inc. | 32,253 | $1,173,000 | 0.61% |
| HEARTLAND ADVISORS INC | 240,724 | $8,755,000 | 0.51% |
| Champlain Investment Partners, LLC | 2,607,033 | $94,818,000 | 0.45% |
| Campbell & CO Investment Adviser LLC | 27,200 | $989,000 | 0.41% |
| S.A. Mason LLC | 5,565 | $202,000 | 0.14% |
| XTX Topco Ltd | 8,240 | $300,000 | 0.10% |
| AIGEN INVESTMENT MANAGEMENT, LP | 15,186 | $552,000 | 0.10% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 16,875 | $614,000 | 0.09% |